Protocolo de tratamiento quirúrgico de la obesidad

  1. Yagüe Lobo, I. 1
  2. Llavero Valero, M. 1
  3. De la Higuera López Frías, M. 1
  1. 1 Departamento de Endocrinología y Nutrición. Clínica Universidad de Navarra. Madrid. España
Aldizkaria:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Argitalpen urtea: 2020

Zenbakien izenburua: Enfermedades endocrinológicas y metabólicas (II)Obesidad y desnutrición

Saila: 13

Zenbakia: 14

Orrialdeak: 807-811

Mota: Artikulua

DOI: 10.1016/J.MED.2020.07.015 DIALNET GOOGLE SCHOLAR

Beste argitalpen batzuk: Medicine: Programa de Formación Médica Continuada Acreditado

Garapen Iraunkorreko Helburuak

Laburpena

In last years, obesity prevalence has grown at an alarming rate. Although the available therapeutic tools are more and more numerous, in grade II and III obesity usually medical treatment is usually insufficient. Surgery is a promising option for those obesity patients in which conventional treatments have been ineffective. In selected patients, chirurgic treatment is very successful in weight loss and long-term maintenance, and above all, in the control of comorbidities associated with obesity. Moreover, overall mortality reduction has be demonstrated. Because the risk and complications of obesity surgery, patients have to be carefully selected by multidisciplinary team in specialized health-centers.

Erreferentzia bibliografikoak

  • Aminian A, Chang J, Brethauer SA, Kim JJ; American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. ASMBS updated position statement on bariatric surgery in class I obesity (BMI 30-35 km2). Surg Obes Relat Dis. 2018;14(8):1071-87.
  • Busetto L, Dicker D, Azran C, Batterham RL, Farpour-Lam-bert N, Fried M, et al. Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management. Obes Facts. 2017;10:597-632.
  • Dixon JB, le Roux CW, Rubino F, Zimmet P. Bariatric surgery for type 2 diabetes. Lancet. 2012;379(9833):2300-11.
  • Lecube A, Monereo S, Rubio MÁ, Martínez-de-Icaya P, Martí A, Salvador J, et al. Prevention, diagnosis, and treatment of obesity. 2016 position statement of the Spanish Society for the Study of Obesity. Endocrinol Diabetes Nutr. 2017;64 Suppl1:15-22.
  • Martín García-Almenta E, Ruiz-Tovar Polo J, Sánchez Santos R. Vía clínica cirugía bariátrica 2017. AEC (Asociación Española de Cirujanos), SECO (Sociedad Española de la Cirugía de la Obesi-dad), FUNSECO (Fundación de la Sociedad Española de la Cirugía de la Obesidad).
  • Rubio MA, Monereo S, Lecube A, Resa J, Masdevall C, de la Cruz Vigo F, et al. Joint position statement of the SEEN-SECO-SEEDO-SED Societies on metabolic surgery for type 2 diabetes mellitus. Endocrinol Nutr. 2013;60(10):547-8.
  • Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al; STAMPEDE Investigators. Bariatric Surgery versus Intensive Me-dical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017;376:641-51
  • Sivakumar J. Nutritional management of surgical patients in the peri-operative. J Obes Eat Disord. 2018;4:1.
  • Thorell A, MacCormick AD, Award S, Reynolds N, Roulin D, De-martines N, et al. Guidelines for perioperative care in bariatric sur-gery: Enhanced Recovery After Surgery (ERAS) Society Recom-mendations. World J Surg. 2016;40:2065-83
  • Vilarrasa García N, López Urdiales R. Complicaciones metabólicas y nu-tricionales de la cirugía bariátrica. En: Manual de endocrinología y nutri-ción SEEN. (webapp)
Datuen iturria: Dialnet